159 related articles for article (PubMed ID: 18769762)
1. Biological evaluation of novel 6-Arylbenzimidazo[1,2-c]quinazoline derivatives as inhibitors of LPS-induced TNF-alpha secretion.
Galarce GD; Foncea RE; Edwards AM; Pessoa-Mahana H; Pessoa-Mahana CD; Ebensperger RA
Biol Res; 2008; 41(1):43-50. PubMed ID: 18769762
[TBL] [Abstract][Full Text] [Related]
2. Semi-synthetic analogs of pinitol as potential inhibitors of TNF-alpha cytokine expression in human neutrophils.
Bhat KA; Shah BA; Gupta KK; Pandey A; Bani S; Taneja SC
Bioorg Med Chem Lett; 2009 Apr; 19(7):1939-43. PubMed ID: 19268586
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines.
Chandrika PM; Yakaiah T; Rao AR; Narsaiah B; Reddy NC; Sridhar V; Rao JV
Eur J Med Chem; 2008 Apr; 43(4):846-52. PubMed ID: 17689837
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anti-inflammatory, and antioxidant activities of 18beta-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors.
Maitraie D; Hung CF; Tu HY; Liou YT; Wei BL; Yang SC; Wang JP; Lin CN
Bioorg Med Chem; 2009 Apr; 17(7):2785-92. PubMed ID: 19278854
[TBL] [Abstract][Full Text] [Related]
5. Boric acid inhibits LPS-induced TNF-alpha formation through a thiol-dependent mechanism in THP-1 cells.
Cao J; Jiang L; Zhang X; Yao X; Geng C; Xue X; Zhong L
J Trace Elem Med Biol; 2008; 22(3):189-95. PubMed ID: 18755394
[TBL] [Abstract][Full Text] [Related]
6. A new three-component reaction: green synthesis of novel isoindolo[2,1-a]quinazoline derivatives as potent inhibitors of TNF-α.
Kumar KS; Kumar PM; Kumar KA; Sreenivasulu M; Jafar AA; Rambabu D; Krishna GR; Reddy CM; Kapavarapu R; Shivakumar K; Priya KK; Parsa KV; Pal M
Chem Commun (Camb); 2011 May; 47(17):5010-2. PubMed ID: 21445417
[TBL] [Abstract][Full Text] [Related]
7. Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro.
Grattendick KJ; Nakashima JM; Feng L; Giri SN; Margolin SB
Int Immunopharmacol; 2008 May; 8(5):679-87. PubMed ID: 18387510
[TBL] [Abstract][Full Text] [Related]
8. A new therapeutic approach in Parkinson's disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents.
Laddha SS; Bhatnagar SP
Bioorg Med Chem; 2009 Oct; 17(19):6796-802. PubMed ID: 19744861
[TBL] [Abstract][Full Text] [Related]
9. Novel diarylheptanoids as inhibitors of TNF-α production.
Dhuru S; Bhedi D; Gophane D; Hirbhagat K; Nadar V; More D; Parikh S; Dalal R; Fonseca LC; Kharas F; Vadnal PY; Vishwakarma RA; Sivaramakrishnan H
Bioorg Med Chem Lett; 2011 Jun; 21(12):3784-7. PubMed ID: 21600765
[TBL] [Abstract][Full Text] [Related]
10. Novel biological response modifiers: phthalimides with tumor necrosis factor-alpha production-regulating activity.
Miyachi H; Azuma A; Ogasawara A; Uchimura E; Watanabe N; Kobayashi Y; Kato F; Kato M; Hashimoto Y
J Med Chem; 1997 Aug; 40(18):2858-65. PubMed ID: 9288167
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity.
Bandgar BP; Patil SA; Totre JV; Korbad BL; Gacche RN; Hote BS; Jalde SS; Chavan HV
Bioorg Med Chem Lett; 2010 Apr; 20(7):2292-6. PubMed ID: 20207143
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antiinflammatory activity of novel phthalimide derivatives, structurally related to thalidomide.
Machado AL; Lima LM; Araújo JX; Fraga CA; Koatz VL; Barreiro EJ
Bioorg Med Chem Lett; 2005 Feb; 15(4):1169-72. PubMed ID: 15686935
[TBL] [Abstract][Full Text] [Related]
13. Mono and bis-6-arylbenzimidazo[1,2-c]quinazolines: a new class of antimicrobial agents.
Rohini R; Shanker K; Reddy PM; Ho YP; Ravinder V
Eur J Med Chem; 2009 Aug; 44(8):3330-9. PubMed ID: 19371978
[TBL] [Abstract][Full Text] [Related]
14. Coumarinic derivatives show anti-inflammatory effects on alveolar macrophages, but their anti-elastase activity is essential to reduce lung inflammation in vivo.
Bissonnette EY; Tremblay GM; Turmel V; Pirotte B; Reboud-Ravaux M
Int Immunopharmacol; 2009 Jan; 9(1):49-54. PubMed ID: 18840548
[TBL] [Abstract][Full Text] [Related]
15. The development of novel inhibitors of tumor necrosis factor-alpha (TNF-alpha) production based on substituted [5,5]-bicyclic pyrazolones.
Laufersweiler MJ; Brugel TA; Clark MP; Golebiowski A; Bookland RG; Laughlin SK; Sabat MP; Townes JA; VanRens JC; De B; Hsieh LC; Heitmeyer SA; Juergens K; Brown KK; Mekel MJ; Walter RL; Janusz MJ
Bioorg Med Chem Lett; 2004 Aug; 14(16):4267-72. PubMed ID: 15261284
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
Maruo S; Kuriyama I; Kuramochi K; Tsubaki K; Yoshida H; Mizushina Y
Bioorg Med Chem; 2011 Oct; 19(19):5803-12. PubMed ID: 21903399
[TBL] [Abstract][Full Text] [Related]
17. Bimodal effect of humic acids on the LPS-induced TNF-alpha release from differentiated U937 cells.
Junek R; Morrow R; Schoenherr JI; Schubert R; Kallmeyer R; Phull S; Klöcking R
Phytomedicine; 2009 May; 16(5):470-6. PubMed ID: 19131228
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives.
Alafeefy AM; Kadi AA; Al-Deeb OA; El-Tahir KE; Al-Jaber NA
Eur J Med Chem; 2010 Nov; 45(11):4947-52. PubMed ID: 20817329
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of Novel Quinazoline Derivatives as Anti-inflammatory Agents against Lipopolysaccharide-induced Acute Lung Injury in Rats.
Hu J; Zhang Y; Dong L; Wang Z; Chen L; Liang D; Shi D; Shan X; Liang G
Chem Biol Drug Des; 2015 Jun; 85(6):672-84. PubMed ID: 25327896
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory and vascularprotective properties of 8-prenylapigenin.
Paoletti T; Fallarini S; Gugliesi F; Minassi A; Appendino G; Lombardi G
Eur J Pharmacol; 2009 Oct; 620(1-3):120-30. PubMed ID: 19686724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
